Lurker Nancy
SEC-identified person · CIK 1450485 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Alkermes plc. ALKS | Director | filed 2024 - 2026 |
| Collegium Pharmaceutical, INC COLL | Director | filed 2025 - 2026 |
| Psivida LTD PSDV | Director · See Remarks | filed 2016 - 2026 |
| Aquestive Therapeutics, Inc. AQST | Director | filed 2018 - 2021 |
| Mallinckrodt plc MNKTQ | Director | filed 2013 - 2016 |
| PDI INC PDII | Director · CEO | filed 2008 - 2015 |
| Auxilium Pharmaceuticals INC AUXL | Director | filed 2011 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.